4min chapter

Blood Cancer Talks cover image

Episode 35. Bispecific Antibodies in Lymphoma with Dr. Michael Dickinson

Blood Cancer Talks

CHAPTER

Treating Relapse After CAR T Cell Therapy in Lymphoma

The challenges and options for treating relapse after CAR T cell therapy, including cytotoxic chemotherapy, lenalidomide, and clinical trials. Biospecific antibodies and their activity in patients like these are also discussed, as well as the potential of molecular tumor characteristics guiding towards specific novel agents or compassionate access programs.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode